Pregled po CROSBI profilu: Marko Skelin (CROSBI Profil: 1067, MBZ: 378932)
Pronađeno 54 radova
-
26.Rahelić, Dario; Matić , Tomas; Skelin, Marko; Klobučar Majanović, Sanja; Bakula, Miro; Deškin, Marin; Bjelinski, Igor; Jurišić Eržen, Dubravka; Krnić, Mladen; Tičinović Kurir, Tina et al.Smjernice za osobe sa šećernom bolešću i zdravstvene djelatnike koji skrbe o oboljelima od šećerne bolesti u Republici Hrvatskoj u vrijeme COVID-19 pandemije Radne skupine Hrvatskog društva za dijabetes i bolesti metabolizma Hrvatskoga liječničkog zbora. // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 142 (2020), 85-88 doi:10.26800/LV-142-3-4-14 (domaća recenzija, pregledni rad, znanstveni)
-
27.Lucijanic, Marko; Jurin, Ivana; Jurin, Hrvoje; Lucijanic, Tomo; Starcevic, Boris; Skelin, Marko; Glasnovic, Anton; Catic, Jasmina; Jurisic, Andjela; Hadzibegovic, IrzalPatients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes // International Journal of Cardiology, 301 (2020), 90-95 doi:10.1016/j.ijcard.2019.10.035 (međunarodna recenzija, članak, ostalo)
-
28.Skelin, Marko; Javor, Eugen; Lucijanic, MarkoAssociation of Early Palliative Care With Survival in Patients With Advanced Lung Cancer // JAMA oncology, 6 (2020), 3; 310-310 doi:10.1001/jamaoncol.2019.6295 (međunarodna recenzija, pismo uredniku, znanstveni)
-
29.Skelin, Marko; Lucijanić, Marko; Javor, EugenThe possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes // European heart journal, 41 (2020), 2; 325-325 doi:10.1093/eurheartj/ehz242 (međunarodna recenzija, pismo uredniku, znanstveni)
-
30.Lucijanic, M.; Jurin, I.; Jurin, H.; Starcevic, B.; Skelin, M.; Glasnovic, A.; Hadzibegovic, I.PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES // HemaSphere, 3 (2019), S1; 122-122 doi:10.1097/01.hs9.0000559572.74207.d4 (međunarodna recenzija, ostalo, znanstveni)
-
31.Suton, P.; Skelin, M.; Luksic, I.Radiotherapy plus cisplatin (CDDP) or cetuximab (C225) in human papilloma-virus (HPV)- associated oropharyngeal cancer (OPC)? A dilemma finally resolved. An updated meta- analysis // Annals of Oncology, 30 (2019), 5; v457-v457 doi:10.1093/annonc/mdz252.017 (međunarodna recenzija, ostalo, znanstveni)
-
32.Skelin, Marko; Lucijanic, Marko; Lucijanic, JelenaDyslipidaemia, a factor worthy of adjustment // European Journal of Heart Failure, 22 (2019), 3; 564-564 doi:10.1002/ejhf.1647 (međunarodna recenzija, pismo uredniku, znanstveni)
-
33.Javor, Eugen; Skelin, Marko; Lucijanić, MarkoLiraglutide in Children and Teens with Type 2 Diabetes // The New England journal of medicine, 381 (2019), 18; 1786-1787 doi:10.1056/NEJMc1912498 (međunarodna recenzija, pismo uredniku, znanstveni)
-
34.Skelin, Marko; Lucijanić, MarkoLonger survival with anti–programmed cell death 1 and development of cutaneous toxic effects, an expected association // JAMA oncology, 5 (2019), 11; 1642-1642 doi:10.1001/jamaoncol.2019.3808 (međunarodna recenzija, pismo uredniku, znanstveni)
-
35.Krnić, Mladen; Marolt, Iris; Skelin, Marko; Grulović, Natasa; Rahelić, DarioAn observational, multicentre study on different insulin glargine U100 titration algorithms used in patients with type 2 diabetes in daily medical practice in Adriatic countries: The ADRESA study // Diabetes research and clinical practice, 150 (2019), 144-149 doi:10.1016/j.diabres.2019.01.001 (međunarodna recenzija, članak, znanstveni)
-
36.Lucijanic, Marko; Skelin, MarkoPlatelet Counts and Risk of Major Bleeding With Ibrutinib // Clinical Lymphoma Myeloma & Leukemia, 19 (2019), 7; e399-e399 doi:10.1016/j.clml.2019.04.001 (međunarodna recenzija, pismo uredniku, znanstveni)
-
37.Skelin, Marko; Lucijanić, Marko; Miketić, TanjaAbove What Age Should Ibrutinib Not Be Given With R-CHOP to Patients With Non-GBC DLBCL? // Journal of clinical oncology, 37 (2019), 28; 2583-2585 doi:10.1200/jco.19.01048 (međunarodna recenzija, pismo uredniku, znanstveni)
-
38.Lucijanić, Marko; Skelin, Marko; Kušec, RajkoSecond primary malignancies in myeloproliferative neoplasms and the role of aspirin // Leukemia, 33 (2019), 10; 2554-2554 doi:10.1038/s41375-019-0553-2 (međunarodna recenzija, pismo uredniku, znanstveni)
-
39.Lucijanić, Marko; Skelin, Marko; Skelin, PetarCatheter ablation compared with drug therapy for atrial fibrillation // JAMA. Journal of the American Medical Association, 322 (2019), 11; 1105-1105 doi:10.1001/jama.2019.10680 (međunarodna recenzija, pismo uredniku, znanstveni)
-
40.Suton, Petar; Skelin, Marko; Rakušić, Zoran; Dokuzović, Stjepan; Lukšić, IvicaIn reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De- ESCALaTE // European archives of oto-rhino-laryngology, 276 (2019), 7; 2113-2114 doi:10.1007/s00405-019-05485-7 (međunarodna recenzija, pismo uredniku, znanstveni)
-
41.Suton, Petar; Skelin, Marko; Rakušić, Zoran; Dokuzović, Stjepan; Lukšić, IvicaCisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE // European archives of oto-rhino-laryngology, 276 (2019), 5; 1275-1281 doi:10.1007/s00405-019-05387-8 (međunarodna recenzija, članak, znanstveni)
-
42.Skelin, Marko; Javor, Eugen; Lucijanić, MarkoAspirin Use and the Risk of Cancer // JAMA oncology, 5 (2019), 6; 912-913 doi:10.1001/jamaoncol.2019.0611 (međunarodna recenzija, pismo uredniku, znanstveni)
-
43.Skelin, Marko; Javor, EugenValue Based Pharmacy: Developing Qualitative Parameters for Drugs and Public Procurement. // Proceedings Book for 4th ECOP (European Conference of Oncology Pharmacy) 25–27 October 2018, Nantes, France
Nantes, Francuska, 2018. (predavanje, međunarodna recenzija, neobjavljeni rad, znanstveni) -
44.Lucijanić, Marko; Čičić, David; Štoos‑Veić, Tajana; Pejša, Vlatko; Lucijanić, Jelena; Fazlić Džankić, Amina; VLasac Glasnović, Josipa; Sorić, Ena; Skelin, Marko; Kušec, RajkoElevated Neutrophil–to–Lymphocyte-ratio and Platelet–to–Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself? // Anticancer Research, 38 (2018), 5; 3157-3163 doi:10.21873/anticanres.12579 (međunarodna recenzija, članak, znanstveni)
-
45.Javor, Eugen; Jakupović, Lejsa; Skelin, MarkoHormone receptor expression and ribociclib activity in hormone receptor positive, human epidermal growth factor receptor 2 negative breast cancer // Libri oncologici : Croatian journal of oncology, 46 (2018), 1; 36-40 doi:.org/10.20471/LO.2018.46.01.06 (domaća recenzija, članak, znanstveni)
-
46.Skelin, Marko; Javor, Eugen; Lucijanić, Marko; Lucijanić, Tomo; Jakupović, Lejsa; Rahelić, DarioThe role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients // International journal of clinical practice, 72 (2018), 12; e13274-e13274 doi:10.1111/ijcp.13274 (međunarodna recenzija, članak, znanstveni)
-
47.Skelin, Marko; Lucijanić, Marko; Javor, EugenRisk stratification according to insulin type // European journal of heart failure, 20 (2018), 10; 1497-1497 doi:.org/10.1002/ejhf.1287 (međunarodna recenzija, pismo uredniku, znanstveni)
-
48.Skelin, Marko; Lucijanić, Tomo; Liberati-Čizmek, Ana-Marija; Klobučar Majanović, Sanja; Lucijanić, Marko; Jakupović, Lejsa; Bakula, Miro; Vučak Lončar, Jelena; Marušić, Srečko; Matić, Tomas et al.Effect of timing of levothyroxine administration on the treatment of hypothyroidism : a three- period crossover randomized study // Endocrine (Basingstoke), 62 (2018), 2; 432-439 doi:10.1007/s12020-018-1686-1 (međunarodna recenzija, članak, znanstveni)
-
49.Lucijanić, Marko; Veletić, Ivo; Rahelić, Dario; Pejša, Vlatko; Čičić, David; Skelin, Marko; Livun, Ana; Tupek, Katarina Marija; Štoos-Veić, Tajana; Lucijanic, Tomo et al.Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis // Wiener klinische Wochenschrift, 130 (2018), 3/4; 126-133 doi:10.1007/s00508-018-1318-z (međunarodna recenzija, članak, znanstveni)
-
50.Lucijanic, Marko; Skelin, Marko; Lucijanic, TomoSurvival analysis, more than meets the eye // Biochemia Medica: The journal of The Croatian Society of Medical Biochemistry and Laboratory Medicine, 27 (2017), 14-18 doi:10.11613/bm.2017.002 (međunarodna recenzija, pregledni rad, znanstveni)
